Worldwide prescription drug revenue - market risk from patent expiration 2020-2028

Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2022

Region

Worldwide

Survey time period

as of August 2022

Supplementary notes

'Total Sales at Risk’ represents the worldwide product sales in the year prior to patent expiry but allocated to the year of expiry. E.g. Plavix had sales of $7.1bn in 2011, this would be shown as ‘At Risk’ in 2012.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical market worldwide "

Other statistics that may interest you Pharmaceutical market worldwide

Overview

7

Segments

8

Companies

8

R&D, patents, new products

8

Outlook

7

Focus: COVID-19 response

7

Further related statistics

20
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.